Company profile: Sirtris Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and development focused on discovering and developing proprietary, orally available small molecule drugs to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes.
Products and services
- Medicamentos para el catarro sin receta: OTC-class medications that alleviate nasal congestion, sneezing, and sore throat, targeting multiple cold symptoms for accessible relief without physician authorization
- Medicamentos para la congestión nasal: Multi-form medications available in various forms to relieve nasal congestion caused by colds, allergies, or sinusitis, delivering targeted decongestion across patient-preferred formats
- Medicamentos para el dolor muscular y articulaciones: NSAID-inclusive medications and muscle relaxants that relieve muscle and joint pain, combining anti-inflammatory and relaxant pharmacology for symptomatic relief of musculoskeletal discomfort
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sirtris Pharmaceuticals
Galectin Therapeutics
HQ: United States
Website
- Description: Provider of galectin-targeted therapeutics and research support, including belapectin (GR-MD-02) in clinical trials for NASH cirrhosis, cancer immunotherapy, and other fibrotic diseases; the NAVIGATE Phase 2b/3 study to prevent esophageal varices in NASH cirrhosis; combination trials with KEYTRUDA; discovery programs for small-molecule and carbohydrate galectin inhibitors; and galectin-3 inhibitor resources for preclinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galectin Therapeutics company profile →
4P Therapeutics
HQ: United States
Website
- Description: Provider of research and development of novel drug delivery technologies and therapeutics, developing pharmaceutical products from pre-clinical testing to clinical manufacturing, with a focus on meeting the needs of patients, physicians and payers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4P Therapeutics company profile →
LP Pharmaceuticals
HQ: China
Website
- Description: Provider of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LP Pharmaceuticals company profile →
Facet Biotech
HQ: United States
Website
- Description: Provider of biotechnology research and development focused on identifying and developing oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Facet Biotech company profile →
Sakura Italia
HQ: Italy
Website
- Description: Provider of research and development of natural products for the well-being of mothers and children.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sakura Italia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sirtris Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sirtris Pharmaceuticals
2.2 - Growth funds investing in similar companies to Sirtris Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sirtris Pharmaceuticals
4.2 - Public trading comparable groups for Sirtris Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →